HLH-like syndromes associate with increased risk of death and…
Identifying which children develop dangerous immune reactions after CAR-T therapy helps doctors catch and treat these complications before they worsen outcomes.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Comparison of obecabtagene autoleucel versus an external control arm…
A faster CAR-T cell therapy shows substantially better survival than standard treatments for hard-to-treat blood cancers in children.
NONEPrognostic impact of measurable residual disease in AML patients…
Checking for remaining leukemia cells after treatment predicts who will do better, making this test useful for monitoring real patients.
NONENeurofilament light chain (NfL) as a surrogate outcome measure for…
A simple blood test for a brain protein tracks disease severity in rare fatal brain disorders, enabling shorter and more feasible clinical trials.
NONEDevelopment and multicenter validation of an AI-driven detection…
Artificial intelligence can reliably spot cancer cells in bone marrow samples, potentially speeding up cancer staging across different hospitals.